Call for Abstract

Pharma Middle East, will be organized around the theme “Conscientious awareness of Pharmacists & Pharmaceutical sciences”

Pharma Middle East 2015 is comprised of 13 tracks and 63 sessions designed to offer comprehensive sessions that address current issues in Pharma Middle East 2015.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 2-1Material characterisation - chemical and physical
  • Track 2-2Morphic form identification
  • Track 2-3Salt selection
  • Track 2-4Compressibility testing
  • Track 2-5Excipient and Process compatibility testing and etc....
  • Track 4-1Drug interactions and adverse drug reactions
  • Track 4-2Advances in Clinical Pharmacy
  • Track 4-3Pharmacy Practice and Pharmacoeconomy
  • Track 4-4Pharmacoepidimiology and Pharmacotherapy
  • Track 4-5Clinical Immunology
  • Track 4-6Clinical molecular genetics
  • Track 4-7Clinical drug development and therapeutics
  • Track 4-8Clinical pharmacy and its key role in treatment
  • Track 4-9Role of clinical pharmacist
  • Track 4-10Research methodology and recent updates on clinical trials
  • Track 7-1Drugs from natural sources
  • Track 7-2Protein structure prediction and molecular simulation and etc.....
  • Track 7-3Exploratory development
  • Track 7-4Biochemistry
  • Track 7-5Protein structure prediction and molecular simulation
  • Track 7-6Telemedicine
  • Track 7-7Molecular drug design
  • Track 7-8Structure aided and computer aided drug design
  • Track 7-9Computational chemistry
  • Track 7-10Phytotherapy & Complementary medicine
  • Track 9-1Regulations and organizations
  • Track 9-2Online pharmacies
  • Track 9-3Multiple drug use
  • Track 9-4Halal medication
  • Track 9-5Role of pharmacists
  • Track 9-6Pharmaceutical services
  • Track 9-7Drug rediscovery
  • Track 9-8Drug safety
  • Track 9-9Implimentation of pharmacogenetics in USA
  • Track 9-10Health care management and providers
  • Track 9-11Clinical Pharmacy Services: patient compliance
  • Track 9-12Good governance in pharmacy and etc.......
  • Track 10-1Drug discovery and development
  • Track 10-2Good manufacturing practices
  • Track 10-3Post- marketing surveillance
  • Track 10-4Product management
  • Track 10-5Waste management
  • Track 10-6Supply chain
  • Track 10-7Clinical studies
  • Track 10-8Pre-clinical studies
  • Track 10-9Industrial pharmaceutics
  • Track 10-10Marketing
  • Track 11-1Genomics and proteomics in Pharmaceutical Industry
  • Track 11-2Clinical engineering in Pharmaceutical Industry
  • Track 11-3Tissue engineering in Pharmaceutical Industry
  • Track 11-4Identification and classification of genes
  • Track 11-5Bio-engineering in Pharmaceutical Industry
  • Track 11-6Engineering models in biomedicine
  • Track 11-7Bionic human
  • Track 11-8Clinical laboratory sciences
  • Track 11-9Biomedical data engineering and etc......
  • Track 12-1FDCA
  • Track 12-2NDA
  • Track 12-3Adulteration
  • Track 12-4Misbranding
  • Track 12-5Exemption in prescription
  • Track 12-6Experimental animal ethics
  • Track 12-7Human trial ethics and etc....